Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 240.75 USD 1.76%
Market Cap: 173.9B USD
Have any thoughts about
Danaher Corp?
Write Note

Danaher Corp
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Danaher Corp
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Danaher Corp
NYSE:DHR
Total Current Liabilities
$7.3B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
5%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Current Liabilities
$14.6B
CAGR 3-Years
23%
CAGR 5-Years
20%
CAGR 10-Years
9%
West Pharmaceutical Services Inc
NYSE:WST
Total Current Liabilities
$516.5m
CAGR 3-Years
-3%
CAGR 5-Years
9%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Total Current Liabilities
$1.2B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
6%
Agilent Technologies Inc
NYSE:A
Total Current Liabilities
$2.4B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
4%
IQVIA Holdings Inc
NYSE:IQV
Total Current Liabilities
$7B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
17%
No Stocks Found

Danaher Corp
Glance View

Market Cap
173.9B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Danaher Corporation, a dynamic and innovative global science and technology company, has established itself as a leader in the life sciences, diagnostics, water quality, and applied solutions sectors. Founded in 1969, Danaher has consistently pursued a strategy of acquiring and nurturing businesses that align with its core focus on advancing health and enhancing the quality of life. By leveraging its strong operational framework known as the Danaher Business System (DBS), the company excels in driving efficiency and innovation across its diverse portfolio. With a commitment to R&D, Danaher continually develops cutting-edge technologies that address critical challenges faced by healthcare, environmental monitoring, and industrial applications. From its beginnings, Danaher has built a reputation for strong organic growth and robust financial performance. Investors are drawn to its disciplined approach to acquisitions, which not only enhances revenue streams but also integrates companies that provide synergistic benefits. With a solid financial foundation characterized by impressive margins and consistently high return on investment, Danaher appears well-positioned for long-term growth. As global demand for health and environmental solutions continues to rise, Danaher’s strategic investments and innovative capabilities make it a compelling choice for investors seeking exposure to the essential sectors of life sciences and diagnostics.

DHR Intrinsic Value
191.95 USD
Overvaluation 20%
Intrinsic Value
Price

See Also

What is Danaher Corp's Total Current Liabilities?
Total Current Liabilities
7.3B USD

Based on the financial report for Sep 27, 2024, Danaher Corp's Total Current Liabilities amounts to 7.3B USD.

What is Danaher Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%

Over the last year, the Total Current Liabilities growth was -22%.

Back to Top